Faculty Perspectives: Next-Generation Sequencing Testing in Oncology | Part 4 of a 4-Part Series

Following the advent of molecularly targeted agents, and more recently, immunotherapy, over the past few decades, we have witnessed dramatic changes in the treatment paradigms for many types of cancer.

The clinical application of assays that utilize next-generation sequencing (NGS) technology is accelerating rapidly in the field of oncology.

The advent of next-generation sequencing (NGS) technologies has revolutionized the way we approach and utilize molecular diagnostic testing in oncology.